Carole Ben-Maimon's Net Worth

$2.36 Million

Estimate Recalculated Sep 8, 2024 07:36PM EST

Who is Carole Ben-Maimon?

Carole Ben-Maimon has an estimated net worth of $2.36 Million. This is based on reported shares across multiple companies, which include Teligent, Inc., Larimar Therapeutics, Inc., and IMPAX LABORATORIES INC.

SEC CIK

Carole Ben-Maimon's CIK is 0001529611

Past Insider Trading and Trends

2019 was Carole Ben-Maimon's most active year for acquiring shares with 6 total transactions. Carole Ben-Maimon's most active month to acquire stocks was the month of December. 2013 was Carole Ben-Maimon's most active year for disposing of shares, totalling 3 transactions. Carole Ben-Maimon's most active month to dispose stocks was the month of September. 2013 saw Carole Ben-Maimon paying a total of $227,462.88 for 88,816 shares, this is the most they've acquired in one year. In 2012 Carole Ben-Maimon cashed out on 1,836 shares for a total of $44,688.24, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Teligent, Inc. No price found

Investor

Carole Ben-Maimon owns 16,000 units of Common Stock.acquired a total of 15,000 shares in Teligent, Inc. at a cost of $23,293.56.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jul 21
Form 4
—
0
—
—
0
Jan 4
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
—
—
0
Oct 2
Form 4
—
0
—
—
0
Jul 1
Form 4
+166.67%
10K
$0.59
$5,885.00
16K
May 30
Form 4
—
0
—
—
0
May 13
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
—
—
0
Jan 2
Form 4
+500.00%
5K
$3.48
$17,408.56
6K
Nov 13
Form 4
—
0
—
—
0
Jan 3
Form 4
—
0
—
—
0
Mar 29
Form 3
—
0
—
—
0
No matching records found

Larimar Therapeutics, Inc. (LRMR) Snapshot price: $8.05

President and CEO

Carole Ben-Maimon owns 332,954 units of Common Stock which is worth $2,680,279.70. From 2020 to 2024 Carole Ben-Maimon acquired a total of 332,954 shares in Larimar Therapeutics, Inc. at a cost of $118,524.90.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+24.78%
66.13K
—
—
332.95K
Jan 17
Form 4
+1.91%
5K
$3.71
$18,525.00
266.83K
May 17
Form 4
+360.73%
205K
—
—
261.83K
Jan 31
Form 4
+126.56%
31.75K
$3.15
$99,999.90
56.83K
Sep 16
Form 4
—
0
—
—
0
May 10
Form 4
—
0
—
—
0
Jan 18
Form 4
—
0
—
—
0
Jan 19
Form 4
—
0
—
—
0
Sep 29
Form 4
∞
25.08K
—
—
25.08K
Jun 26
Form 3
—
0
—
—
0
No matching records found

IMPAX LABORATORIES INC No price found

President, Global Pharm.

Carole Ben-Maimon owns 85,914 units of Common Stock. From 2011 to 2014 Carole Ben-Maimon acquired a total of 88,149 shares in IMPAX LABORATORIES INC at a cost of $227,462.88, Carole also disposed a total of 2,235 shares of IMPAX LABORATORIES INC equalling to $52,109.64.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+36.56%
23K
—
—
85.91K
May 14
Form 4
+11.99%
6.73K
$18.93
$127,474.62
62.91K
Oct 25
Form 4
+10.38%
5.28K
$18.93
$99,988.26
56.18K
Oct 10
Form 4
-0.78%
-399.00
$18.60
-$7,421.40
50.9K
May 23
Form 4
+93.60%
24.8K
—
—
51.3K
May 15
Form 4
-6.48%
-1.84K
$24.34
-$44,688.24
26.5K
Oct 28
Form 4
+18.05%
4.33K
—
—
28.33K
May 23
Form 4
∞
24K
—
—
24K
Oct 28
Form 3
—
0
—
—
0
No matching records found